
Amber D. Steele
Examiner (ID: 2430, Phone: (571)272-5538 , Office: P/1676 )
| Most Active Art Unit | 1658 |
| Art Unit(s) | 1654, 1639, 1658, 1676 |
| Total Applications | 1302 |
| Issued Applications | 628 |
| Pending Applications | 166 |
| Abandoned Applications | 538 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10665063
[patent_doc_number] => 20160011207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-14
[patent_title] => 'DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/648802
[patent_app_country] => US
[patent_app_date] => 2013-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17646
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14648802
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/648802 | DIAGNOSIS AND THERAPY OF CHRONIC INFLAMMATION-INDUCED DISORDERS | Dec 4, 2013 | Abandoned |
Array
(
[id] => 12172067
[patent_doc_number] => 09890194
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-13
[patent_title] => 'Epitope and its use'
[patent_app_type] => utility
[patent_app_number] => 14/441248
[patent_app_country] => US
[patent_app_date] => 2013-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 3684
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441248
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441248 | Epitope and its use | Nov 6, 2013 | Issued |
Array
(
[id] => 10406663
[patent_doc_number] => 20150291672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'Contact Lens Surface Modification with Hyaluronic Acid (HA) Binding Peptide for HA Accumulation and Retention'
[patent_app_type] => utility
[patent_app_number] => 14/439270
[patent_app_country] => US
[patent_app_date] => 2013-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 3501
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439270
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439270 | Contact Lens Surface Modification with Hyaluronic Acid (HA) Binding Peptide for HA Accumulation and Retention | Oct 31, 2013 | Abandoned |
Array
(
[id] => 10362134
[patent_doc_number] => 20150247139
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-03
[patent_title] => 'RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS'
[patent_app_type] => utility
[patent_app_number] => 14/427234
[patent_app_country] => US
[patent_app_date] => 2013-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 10830
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427234
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427234 | Recombinant clostridium botulinum neurotoxins | Oct 30, 2013 | Issued |
Array
(
[id] => 11318161
[patent_doc_number] => 09516893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-13
[patent_title] => 'Use of tryptophan rich protein hydrolysates'
[patent_app_type] => utility
[patent_app_number] => 14/404878
[patent_app_country] => US
[patent_app_date] => 2013-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14490
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404878
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404878 | Use of tryptophan rich protein hydrolysates | Oct 29, 2013 | Issued |
Array
(
[id] => 9477293
[patent_doc_number] => 20140134756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-15
[patent_title] => 'BIOMOLECULAR RECOGNITION OF CRYSTAL DEFECTS'
[patent_app_type] => utility
[patent_app_number] => 14/059639
[patent_app_country] => US
[patent_app_date] => 2013-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9658
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14059639
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/059639 | BIOMOLECULAR RECOGNITION OF CRYSTAL DEFECTS | Oct 21, 2013 | Abandoned |
Array
(
[id] => 10470163
[patent_doc_number] => 20150355179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-12-10
[patent_title] => 'CDKACT BIOSENSORS-FLUORESCENT POLYPEPTIDE TO PROBE THE ACTIVITY OF CDK/CYCLIN KINASES IN VITRO, IN CELLULO AND IN VIVO'
[patent_app_type] => utility
[patent_app_number] => 14/433934
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 14153
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14433934
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/433934 | CDKACT BIOSENSORS-FLUORESCENT POLYPEPTIDE TO PROBE THE ACTIVITY OF CDK/CYCLIN KINASES IN VITRO, IN CELLULO AND IN VIVO | Oct 9, 2013 | Abandoned |
Array
(
[id] => 9363155
[patent_doc_number] => 20140073028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'MEK Ligands and Polynucleotides Encoding MEK Ligands'
[patent_app_type] => utility
[patent_app_number] => 14/046454
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 10159
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046454 | MEK ligands and polynucleotides encoding MEK ligands | Oct 3, 2013 | Issued |
Array
(
[id] => 9685876
[patent_doc_number] => 20140242640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'Methods of Making Nanotechnological and Macromolecular Biomimetic Structures'
[patent_app_type] => utility
[patent_app_number] => 14/039717
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 19425
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14039717
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/039717 | Methods of Making Nanotechnological and Macromolecular Biomimetic Structures | Sep 26, 2013 | Abandoned |
Array
(
[id] => 11915407
[patent_doc_number] => 09783585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-10-10
[patent_title] => 'Compositions and methods for increasing the expression and signalling of proteins on cell surfaces'
[patent_app_type] => utility
[patent_app_number] => 14/427090
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 13
[patent_no_of_words] => 13036
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14427090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/427090 | Compositions and methods for increasing the expression and signalling of proteins on cell surfaces | Sep 25, 2013 | Issued |
Array
(
[id] => 11389575
[patent_doc_number] => 09550809
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-24
[patent_title] => 'High affinity metal-oxide binding peptides with reversible binding'
[patent_app_type] => utility
[patent_app_number] => 14/034420
[patent_app_country] => US
[patent_app_date] => 2013-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 15248
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14034420
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/034420 | High affinity metal-oxide binding peptides with reversible binding | Sep 22, 2013 | Issued |
Array
(
[id] => 12037648
[patent_doc_number] => 09815867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Peptide for inhibiting vascular endothelial growth factor receptor'
[patent_app_type] => utility
[patent_app_number] => 14/424192
[patent_app_country] => US
[patent_app_date] => 2013-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 14
[patent_no_of_words] => 13405
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424192
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424192 | Peptide for inhibiting vascular endothelial growth factor receptor | Sep 1, 2013 | Issued |
Array
(
[id] => 10142462
[patent_doc_number] => 09175263
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-11-03
[patent_title] => 'Methods and compositions for targeting progenitor cell lines'
[patent_app_type] => utility
[patent_app_number] => 13/972695
[patent_app_country] => US
[patent_app_date] => 2013-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 19
[patent_no_of_words] => 25086
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13972695
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/972695 | Methods and compositions for targeting progenitor cell lines | Aug 20, 2013 | Issued |
Array
(
[id] => 9319319
[patent_doc_number] => 20140051657
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-20
[patent_title] => 'METHODS AND SYSTEMS FOR SCREENING COMPOSITIONS COMPRISING NON-ANTICOAGULANT SULFATED POLYSACCHARIDES'
[patent_app_type] => utility
[patent_app_number] => 13/964684
[patent_app_country] => US
[patent_app_date] => 2013-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 33343
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13964684
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/964684 | Methods and systems for screening compositions comprising non-anticoagulant sulfated polysaccharides | Aug 11, 2013 | Issued |
Array
(
[id] => 11303705
[patent_doc_number] => 09511087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Use of antithrombin in extracorporeal membrane oxygenation'
[patent_app_type] => utility
[patent_app_number] => 14/239943
[patent_app_country] => US
[patent_app_date] => 2013-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6502
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239943
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239943 | Use of antithrombin in extracorporeal membrane oxygenation | Aug 1, 2013 | Issued |
Array
(
[id] => 12445473
[patent_doc_number] => 09981004
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-29
[patent_title] => Inhibition of TREM receptor signaling with peptide variants
[patent_app_type] => utility
[patent_app_number] => 13/941445
[patent_app_country] => US
[patent_app_date] => 2013-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 23858
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13941445
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/941445 | Inhibition of TREM receptor signaling with peptide variants | Jul 11, 2013 | Issued |
Array
(
[id] => 11535931
[patent_doc_number] => 09610324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-04-04
[patent_title] => 'Apolipoprotein mixtures'
[patent_app_type] => utility
[patent_app_number] => 14/413918
[patent_app_country] => US
[patent_app_date] => 2013-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 27
[patent_no_of_words] => 32444
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14413918
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/413918 | Apolipoprotein mixtures | Jul 10, 2013 | Issued |
Array
(
[id] => 10103870
[patent_doc_number] => 09139645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Peptides and related molecules that bind to TALL-1'
[patent_app_type] => utility
[patent_app_number] => 13/938141
[patent_app_country] => US
[patent_app_date] => 2013-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 40
[patent_no_of_words] => 23348
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13938141
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/938141 | Peptides and related molecules that bind to TALL-1 | Jul 8, 2013 | Issued |
Array
(
[id] => 10290663
[patent_doc_number] => 20150175662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-25
[patent_title] => 'NOVEL PEPTIDES AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/412020
[patent_app_country] => US
[patent_app_date] => 2013-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8973
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/412020 | Peptides and use thereof | Jul 2, 2013 | Issued |
Array
(
[id] => 11697662
[patent_doc_number] => 09687560
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-27
[patent_title] => 'Skin-permeating peptide'
[patent_app_type] => utility
[patent_app_number] => 14/404928
[patent_app_country] => US
[patent_app_date] => 2013-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5719
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404928 | Skin-permeating peptide | May 30, 2013 | Issued |